Abarelix is a synthetic decapeptide antagonist to gonadotropin releasing hormone (GnRH). It directly and competitively binds and blocks the gonadotropin releasing hormone receptors in the anterior pituitary, which inhibits the secretion and release of the luteinizing hormone (LH) and follicle stimulating hormone (FSH). For men, the inhibition of LH secretion prevents the release of testosterone. Therefore, it can relieve symptoms associated with prostate hypertrophy or prostate cancer.
CAT# | 10-101-60 |
Chemical Structure | ![]() |
CAS | 183552-38-7 |
Synonyms/Alias | Abarelix;Abarelix-Depot-M;R-3827;R3827;R 3827; PPI149; PPI-149; PPI 149; R3827; R-3827; R 3827. Abarelix; Abarelix acetate. Brand name: Plenaxis.N-acetyl-3-(2-naphthyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridyl)-D-alanyl-L-seryl-N-methyl-L-tyrosyl-D-asparagyl-L-leucyl-N6-isopropyl-L-lysyl-L-prolyl-D-alaninamide |
Chemical Name | (2R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-acetamido-3-naphthalen-2-ylpropanoyl]amino]-3-(4-chlorophenyl)propanoyl]amino]-3-pyridin-3-ylpropanoyl]amino]-3-hydroxypropanoyl]-methylamino]-3-(4-hydroxyphenyl)propanoyl]amino]-N-[(2S)-1-[[(2S)-1-[(2S)-2-[[(2R)-1-amino-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxo-6-(propan-2-ylamino)hexan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]butanediamide |
M.F/Formula | C72H95ClN14O14 |
M.W/Mr. | 1416.086 |
Sequence | One Letter Code: XXXSYNLXPA Three Letter Code: Ac-D-2Nal-D-Phe(4-Cl)-D-3Pal-Ser-N(Me)Tyr-D-Asn-Leu-Lys(iPr)-Pro-D-Ala-NH2 |
Application | Hormone antagonist and an antineoplastic agent |
Appearance | Solid powder |
Activity | Antagonist |
Biological Activity | Abarelix is a polypeptide compound composed of ten natural and non-natural amino acid resiudes in a linear sequence. It has a role as a hormone antagonist and an antineoplastic agent. |
Target | Gonadotropin-releasing hormone receptor |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).